SESSION TYPE: Bronchoscopy and Interventional Procedures Posters
PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PM
PURPOSE: Although the usefulness or effectiveness of airway stent insertion to the patients with malignant airway stenosis has been described, there is little verification whether this treatment is really improving the patient survival. Previous reports have described the survival after stent insertion was 94-109 days (3.5 months). Now, we analyzed the survival after stent insertion only in the patients with advanced primary lung cancer.
METHODS: Between May 2005 to Jan 2011, 26 cancer patients with central airway stenosis were inserted airway stents. Eleven of them were primary lung cancer patients. The type of stent, additional treatment after stenting, complications or symptoms related stents, and survival after stent insertion were analyzed in those 11 patients.
RESULTS: Six were male and five were female, mean age was 69.3 with range of 61-89 years. Five patients were adenocarcinoma, 3 were squamous cell carcinoma, 1 was adenosquamous carcinoma, 1 was small cell carcinoma, and another one was unknown histology. Four patients were stage IIIB, and 7 were stage IV. All 11 patients complained severe dyspnea, and all of them dramatically improved their symptoms after stent insertion. Eight of 11 patients (73%) were performed chemotherapy or radiotherapy after stent insertion. Three patients complained cough or discomfort after the insertion, and one of them was removed the stent due to improvement of airway stenosis after chemo-radio therapy. Seven patients died of lung cancer, one by myocardial infarction, one by suicide, and only one patient was still alive. The overall survival was 191.7 days (6.4 months).
CONCLUSIONS: Stent therapy to the patients with advanced primary lung cancer could not only avoid suffocation but also improve the survival.
CLINICAL IMPLICATIONS: Airway stent got a great role as a “bridge” to the next aggressive therapy.
DISCLOSURE: The following authors have nothing to disclose: Yusuke Okamoto, Masahiro Mitsuoka, Yasuhiro Terazaki, Shozo Sakata, Shigeki Morita
No Product/Research Disclosure InformationSaga Prefectural Hospital, Saga, Japan